• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cytokine Profiles of Severe Influenza Virus-Related Complications in Children

tetano

Editor, Senior Moderator
Front Immunol. 2017 Nov 6;8:1423. doi: 10.3389/fimmu.2017.01423. eCollection 2017.
[h=1]Cytokine Profiles of Severe Influenza Virus-Related Complications in Children.[/h] Fiore-Gartland A[SUP]1[/SUP], Panoskaltsis-Mortari A[SUP]2[/SUP], Agan AA[SUP]3[/SUP], Mistry AJ[SUP]3[/SUP], Thomas PG[SUP]4[/SUP], Matthay MA[SUP]5,[/SUP][SUP]6[/SUP]; PALISI PICFlu Investigators, Hertz T[SUP]1,[/SUP][SUP]7,[/SUP][SUP]8[/SUP], Randolph AG[SUP]3,[/SUP][SUP]9,[/SUP][SUP]10[/SUP].
[h=3]Collaborators (101)[/h]

[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Rationale:[/h] Effective immunomodulatory therapies for children with life-threatening "cytokine storm" triggered by acute influenza infection are lacking. Understanding the immune profiles of children progressing to severe lung injury and/or septic shock could provide insight into pathogenesis.
[h=4]Objectives:[/h] To compare the endotracheal and serum cytokine profiles of children with influenza-related critical illness and to identify their associations with severe influenza-associated complications.
[h=4]Methods:[/h] Children with influenza-related critical illness were enrolled across 32 hospitals in development (N = 171) and validation (N = 73) cohorts (December 2008 through May 2016). Concentrations of 42 cytokines were measured in serum and endotracheal samples and clustered into modules of covarying cytokines. Relative concentrations of cytokines and cytokine modules were tested for associations with acute lung injury (ALI), shock requiring vasopressors, and death/ECMO.
[h=4]Measurements and main results:[/h] Modules of covarying cytokines were more significantly associated with disease severity than individual cytokines. In the development cohort, increased levels of a serum module containing IL6, IL8, IL10, IP10, GCSF, MCP1, and MIP1α [shock odds ratio (OR) = 3.37, family-wise error rate (FWER) p < 10[SUP]-4[/SUP]], and decreased levels of a module containing EGF, FGF2, SCD40L, and PAI-1 (shock OR = 0.43, FWER p = 0.002), were both associated with ALI, shock, and death-ECMO independent of age and bacterial coinfection. Both of these associations were confirmed in the validation cohort. Endotracheal and serum cytokine associations differed markedly and were differentially associated with clinical outcomes.
[h=4]Conclusion:[/h] We identified strong positive and negative associations of cytokine modules with the most severe influenza-related complications in children, providing new insights into the pathogenesis of influenza-related critical illness in children. Effective therapies may need to target mediators of both inflammation and repair.


[h=4]KEYWORDS:[/h] acute lung injury; cytokine; inflammation; influenza; septic shock

PMID: 29163498 PMCID: PMC5681736 DOI: 10.3389/fimmu.2017.01423
Free full text
 
Back
Top Bottom